Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitis

Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disabling long-term condition of unknown cause. The National Institute for Health and Care Excellence (NICE) published a guideline in 2021 that highlighted the seriousness of the condition, but also recommended that graded exercise therapy (GET) should not be used and cognitive–behavioural therapy should only be used to manage symptoms and reduce distress, not to aid recovery. This U-turn in recommendations from the previous 2007 guideline is controversial. We suggest that the controversy stems from anomalies in both processing and interpretation of the evidence by the NICE committee. The committee: (1) created a new definition of CFS/ME, which ‘downgraded’ the certainty of trial evidence; (2) omitted data from standard trial end points used to assess efficacy; (3) discounted trial data when assessing treatment harm in favour of lower quality surveys and qualitative studies; (4) minimised the importance of fatigue as an outcome; (5) did not use accepted practices to synthesise trial evidence adequately using GRADE (Grading of Recommendations, Assessment, Development and Evaluations trial evidence); (6) interpreted GET as mandating fixed increments of change when trials defined it as collaborative, negotiated and symptom dependent; (7) deviated from NICE recommendations of rehabilitation for related conditions, such as chronic primary pain and (8) recommended an energy management approach in the absence of supportive research evidence. We conclude that the dissonance between this and the previous guideline was the result of deviating from usual scientific standards of the NICE process. The consequences of this are that patients may be denied helpful treatments and therefore risk persistent ill health and disability.

[1]  B. Barry,et al.  The effectiveness of activity pacing interventions for people with chronic fatigue syndrome: a systematic review and meta-analysis , 2022, Disability and rehabilitation.

[2]  T. Chalder,et al.  A systematic literature review of randomized controlled trials evaluating prognosis following treatment for adults with chronic fatigue syndrome , 2022, Psychological Medicine.

[3]  S. Flottorp,et al.  New NICE guideline on chronic fatigue syndrome: more ideology than science? , 2022, The Lancet.

[4]  I. Torjesen Exclusive: Four members of NICE’s guideline committee on ME/CSF stand down , 2021, BMJ.

[5]  Steven P. Cohen,et al.  Nociplastic pain: towards an understanding of prevalent pain conditions , 2021, The Lancet.

[6]  J. Etherington,et al.  Adverse outcomes in trials of graded exercise therapy for adult patients with chronic fatigue syndrome. , 2021, Journal of psychosomatic research.

[7]  D. Wade,et al.  Updated NICE guidance on chronic fatigue syndrome , 2020, BMJ.

[8]  A. Esmail,et al.  Myalgic encephalomyelitis (or encephalopathy) / chronic fatigue syndrome: diagnosis and management: Involving adults with severe ME/CFS symptomsin developing a NICE guideline on Myalgic encephalomyelitis/Chronic fatigue syndrome:diagnosis and management , 2020 .

[9]  J. Sterne,et al.  Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study , 2020, BMJ.

[10]  G. Millet,et al.  Post-Exertional Malaise in People with Chronic Cancer-Related Fatigue. , 2019, Journal of pain and symptom management.

[11]  D. Ashcroft,et al.  Prevalence of comorbid mental and physical illnesses and risks for self-harm and premature death among primary care patients diagnosed with fatigue syndromes , 2019, Psychological Medicine.

[12]  Blair H. Smith,et al.  The IASP classification of chronic pain for ICD-11: chronic neuropathic pain , 2019, Pain.

[13]  L. Aliste,et al.  Comorbidity in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Nationwide Population-Based Cohort Study. , 2017, Psychosomatics.

[14]  F. Pesola,et al.  Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial , 2017, The Lancet.

[15]  David Moher,et al.  CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. , 2017, Annals of internal medicine.

[16]  P. Glasziou,et al.  Guidance for Modifying the Definition of Diseases: A Checklist , 2017, JAMA internal medicine.

[17]  D. Stott,et al.  'Across the pond'-a response to the NICE guidelines for management of multi-morbidity in older people. , 2017, Age and ageing.

[18]  J. Price,et al.  Exercise therapy for chronic fatigue syndrome. , 2017, The Cochrane database of systematic reviews.

[19]  Gordon H Guyatt,et al.  GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction , 2016, British Medical Journal.

[20]  T. Chalder,et al.  Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. , 2015, The lancet. Psychiatry.

[21]  S. Maes,et al.  Differential effects of behavioral interventions with a graded physical activity component in patients suffering from Chronic Fatigue (Syndrome): An updated systematic review and meta-analysis. , 2015, Clinical psychology review.

[22]  M. McDonagh,et al.  Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop , 2015, Annals of Internal Medicine.

[23]  Anthony L. Johnson,et al.  Adverse events and deterioration reported by participants in the PACE trial of therapies for chronic fatigue syndrome , 2014, Journal of psychosomatic research.

[24]  Daniel J Clauw,et al.  Fibromyalgia: a clinical review. , 2014, JAMA.

[25]  P. Glasziou,et al.  Exercise therapy for chronic fatigue syndrome (individual patient data) , 2014, Cochrane Database of Systematic Reviews.

[26]  K. Malterud,et al.  Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review , 2014, BMJ Open.

[27]  James E. Graham,et al.  Exercise intolerance in individuals with postconcussion syndrome. , 2013, Journal of athletic training.

[28]  A. Light,et al.  Differences in Metabolite-Detecting, Adrenergic, and Immune Gene Expression After Moderate Exercise in Patients With Chronic Fatigue Syndrome, Patients With Multiple Sclerosis, and Healthy Controls , 2012, Psychosomatic medicine.

[29]  V. Hunot,et al.  Cognitive behaviour therapy for chronic fatigue syndrome in adults , 2022 .

[30]  J. Malouff,et al.  Efficacy of cognitive behavioral therapy for chronic fatigue syndrome: a meta-analysis. , 2008, Clinical psychology review.

[31]  R. Baker,et al.  Diagnosis and management of chronic fatigue syndrome or myalgic encephalomyelitis (or encephalopathy): summary of NICE guidance , 2007, BMJ : British Medical Journal.

[32]  Susanne Hempel,et al.  Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. , 2006, Journal of the Royal Society of Medicine.

[33]  P. Sullivan,et al.  Chronic fatigue in a population sample: definitions and heterogeneity , 2005, Psychological Medicine.

[34]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[35]  D. Buchwald,et al.  Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. , 1994, Archives of internal medicine.

[36]  M. Sharpe,et al.  A Report–Chronic Fatigue Syndrome: Guidelines for Research , 1991, Journal of the Royal Society of Medicine.

[37]  G. Fraedrich,et al.  Juvenile recurrent respiratory papillomatosis: Still a mystery disease with difficult management , 2007, Head & neck.

[38]  H. Schünemann,et al.  [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.] , 2017, Recenti progressi in medicina.

[39]  K. Friedman Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. , 2015, Military medicine.

[40]  Comparison of adaptive pacing therapy , cognitive behaviour therapy , graded exercise therapy , and specialist medical care for chronic fatigue syndrome ( PACE ) : a randomised trial , 2013 .

[41]  F. J. Ballina García,et al.  [Fibromyalgia. Clinical review]. , 1995, Revista clinica espanola.